A
Autolus Therapeutics plc (AUTL)
NMS – Real Time Price. Currency in USD
1.60
+0.02 (1.27%)
At close: May 12, 2026, 4:00 PM EDT
1.60
0.00 (0.00%)
After-hours: May 12, 2026, 7:37 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.60
+0.02 (1.27%)
At close: May 12, 2026, 4:00 PM EDT
1.60
0.00 (0.00%)
After-hours: May 12, 2026, 7:37 PM EDT
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19 chimeric antigen receptor. It also develops obe-cel, which is in phase 1 to treat systemic lupus erythematosus, progressive multiple sclerosis, B-NHL and CLL, and CNS lymphoma; obe-cel, which is in phase 2 to treat pediatric B-ALL and lupus nephritis; AUTO1/22 to treat pediatric B-ALL, which is phase 1; AUTO8, which is in phase 1 to treat multiple myeloma and light chain amyloidosis; AUTO4/5, which is in preclinical stage to treat peripheral TCL; AUTO6NG, which is in phase 1 to treat neuroblastoma; and AUTO9, which is in preclinical stage to treat acute myeloid leukemia. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.
| Name | Position |
|---|---|
| Dr. Matthias Will M.D. | Senior VP & Chief Development Officer |
| Mr. Patrick McIlvenny | Senior VP of Finance, Chief Accounting Officer & Principal Accounting Officer |
| Mr. Robert F. Dolski | Senior VP & CFO |
| Ms. Miranda Neville | Senior VP & Chief Technology Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-29 | 8-K | d113906d8k.htm |
| 2026-04-16 | 8-K | autl-20260414.htm |
| 2026-04-15 | DEL AM | d132407ddelam.htm |
| 2026-04-13 | S-3 | d132407ds3.htm |
| 2026-04-08 | 8-K | autl-20260408.htm |
| 2026-03-27 | 8-K | autl-20260327.htm |
| 2026-03-27 | 10-K | autl-20251231.htm |
| 2025-12-02 | 8-K | autl-20251201.htm |
| 2025-11-18 | S-8 | d813559ds8.htm |
| 2025-11-12 | 8-K | autl-20251112.htm |